Complete Filing Data
Bluejay Diagnostics, Inc. reported Stockholders Equity of $5.98 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bluejay Diagnostics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$6.8M | -$7.7M | -$10.0M | -$9.3M | -$3.5M | -$1.2M |
| Research And Development Expense | $3.0M | $3.5M | $5.7M | $4.2M | $1.1M | $527.3K |
| Operating Income Loss | -$7.0M | -$7.2M | -$10.3M | -$9.3M | -$3.2M | -$1.2M |
| Operating Expenses | $7.0M | $7.2M | $10.3M | $9.4M | $3.2M | $1.2M |
| General And Administrative Expense | $3.9M | $3.7M | $4.3M | $4.8M | $1.8M | $596.1K |
| Nonoperating Income Expense | $104.5K | -$548.2K | $357.3K | $20.8K | -$258.1K | $38.1K |
| Selling And Marketing Expense | $8.3K | $283.4K | $451.4K | $289.7K | $73.0K | |
| Other Nonoperating Income Expense | $7.8K | $129.0K | $192.4K | $168.5K | ||
| Asset Impairment Charges | $42.9K | $3.4K | $1.8K | $237.3K | ||
| Interest Income Expense Net | -$367.5K | -$27.0K | ||||
| Interest Expense Nonoperating | $839.00 | $823.0K | ||||
| Selling General And Administrative Expense | $283.4K | $451.4K | ||||
| Revenues | $249.0K | |||||
| Cost Of Goods And Services Sold | $200.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.6M | -$2.0M | -$1.9M | -$1.5M | -$2.5M | -$2.3M | -$2.3M | -$2.8M | -$2.5M | -$3.0M | -$1.9M | -$2.0M | -$1.2M | $640.2K | -$194.2K | -$128.0K | -$179.6K | -$306.6K |
| Research And Development Expense | $785.6K | $889.9K | $784.8K | $551.7K | $1.0M | $1.3M | $1.4M | $1.7M | $1.4M | $1.4M | $756.3K | $694.8K | $442.5K | $226.0K | $24.2K | $2.7K | ||
| Operating Income Loss | -$1.6M | -$2.0M | -$1.9M | -$1.4M | -$1.9M | -$2.4M | -$2.3M | -$2.9M | -$2.7M | -$2.8M | -$2.0M | -$2.1M | -$958.0K | -$666.1K | -$233.2K | -$148.2K | ||
| Operating Expenses | $1.6M | $2.0M | $1.9M | $1.4M | $1.9M | $2.4M | $2.3M | $2.9M | $2.7M | $2.8M | $2.0M | $2.1M | $958.0K | $666.1K | $233.2K | $148.2K | ||
| General And Administrative Expense | $831.3K | $1.1M | $1.1M | $809.2K | $862.5K | $1.1M | $963.5K | $1.1M | $1.2M | $1.3M | $1.2M | $1.3M | $445.1K | $389.8K | $139.9K | $131.1K | ||
| Nonoperating Income Expense | $19.3K | $28.8K | $24.5K | -$120.4K | -$580.1K | $99.6K | $43.2K | $90.4K | $139.7K | -$149.7K | $48.3K | $54.9K | -$235.4K | $25.8K | $39.0K | $20.2K | ||
| Selling And Marketing Expense | $753.00 | $305.00 | $6.4K | $154.3K | $148.0K | $146.1K | $81.4K | $53.7K | $70.4K | $50.3K | $69.1K | $14.4K | ||||||
| Other Nonoperating Income Expense | $554.00 | -$275.00 | $8.6K | $30.9K | $99.6K | $43.2K | $90.4K | $139.7K | $60.4K | |||||||||
| Asset Impairment Charges | ||||||||||||||||||
| Interest Income Expense Net | -$237.4K | -$59.2K | $27.1K | $15.8K | ||||||||||||||
| Interest Expense Nonoperating | $200.00 | $222.00 | $190.6K | $626.5K | ||||||||||||||
| Selling General And Administrative Expense | $6.4K | -$19.6K | $148.0K | $146.1K | ||||||||||||||
| Revenues | $249.0K | |||||||||||||||||
| Cost Of Goods And Services Sold | $200.1K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.0M | $5.7M | $2.9M | $11.5M | $20.4M | -$4.2M | -$2.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.2M | $4.3M | $2.2M | $10.1M | $19.0M | $912.4K | $96.0K |
| Retained Earnings Accumulated Deficit | -$41.5M | -$34.7M | -$27.0M | -$17.0M | -$7.7M | -$4.2M | |
| Property Plant And Equipment Net | $1.5M | $1.5M | $1.3M | $1.2M | $337.4K | $459.1K | |
| Prepaid Expense And Other Assets Current | $276.0K | $596.9K | $747.3K | $1.7M | $1.6M | $61.1K | |
| Liabilities And Stockholders Equity | $7.1M | $6.7M | $4.9M | $13.5M | $21.0M | $1.5M | |
| Liabilities | $1.1M | $927.9K | $2.0M | $2.0M | $637.2K | $1.8M | |
| Cash And Cash Equivalents At Carrying Value | $5.2M | $4.3M | $2.2M | $10.1M | $19.0M | $912.4K | |
| Assets Current | $5.5M | $4.9M | $3.2M | $11.8M | $20.7M | $1.1M | |
| Assets | $7.1M | $6.7M | $4.9M | $13.5M | $21.0M | $1.5M | |
| Accounts Payable Current | $214.3K | $145.1K | $491.5K | $635.8K | $295.8K | $374.9K | |
| Common Stock Value | $60.00 | $14.00 | $101.00 | $2.0K | $315.00 | ||
| Other Assets Noncurrent | $7.9K | $35.3K | $28.7K | $35.2K | $21.0K | ||
| Liabilities Current | $1.1M | $810.4K | $1.8M | $1.6M | $637.2K | ||
| Operating Lease Right Of Use Asset | $113.3K | $209.8K | $333.3K | $465.5K | |||
| Operating Lease Liability Noncurrent | $20.2K | $109.0K | $190.0K | $323.9K | |||
| Other Liabilities Noncurrent | $4.5K | $8.6K | $12.3K | $15.8K | |||
| Operating Lease Liability Current | $100.0K | $113.3K | $163.0K | $168.7K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $96.5K | $123.5K | $132.2K | $149.8K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $862.9K | $2.1M | -$7.9M | -$8.9M | |||
| Accrued Liabilities Current | $804.9K | $552.0K | $1.1M | $835.7K | $341.4K | $133.8K | |
| Additional Paid In Capital Common Stock | $47.5M | $40.4M | $29.8M | $28.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $10.1M | $19.0M | $912.4K | ||||
| Accretion Of Series Redeemable Convertible Preferred Stock Dividend | -$127.9K | -$271.7K | |||||
| Repayments Of Notes Payable | $2.0M | $289.6K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$8.9M | $18.1M | $816.4K | ||||
| Accounts Payable And Other Accrued Liabilities Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.7M | $5.3M | $3.9M | $7.2M | $8.6M | $3.4M | $5.2M | $6.4M | $9.2M | $13.8M | $16.7M | $18.5M | -$1.1M | $123.5K | -$4.3M | -$3.7M | -$3.6M | -$3.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.1M | $4.4M | $3.1M | $5.8M | $8.1M | $2.7M | $5.1M | $5.1M | $6.8M | $13.3M | $15.3M | $17.1M | |||||||||
| Retained Earnings Accumulated Deficit | -$40.1M | -$38.5M | -$36.5M | -$33.2M | -$31.8M | -$29.3M | -$24.6M | -$22.4M | -$19.5M | -$14.6M | -$11.7M | -$9.7M | -$6.2M | ||||||||
| Property Plant And Equipment Net | $1.4M | $1.5M | $1.5M | $1.5M | $1.6M | $1.3M | $1.3M | $1.5M | $1.5M | $1.2M | $409.1K | $343.7K | $358.8K | ||||||||
| Prepaid Expense And Other Assets Current | $169.4K | $305.5K | $456.1K | $811.9K | $960.0K | $788.6K | $1.5M | $1.5M | $2.1M | $646.9K | $1.0M | $1.3M | $451.4K | ||||||||
| Liabilities And Stockholders Equity | $4.9M | $6.4M | $5.3M | $8.4M | $10.9M | $5.1M | $8.2M | $8.5M | $10.9M | $15.7M | $18.1M | $20.1M | $3.6M | ||||||||
| Liabilities | $1.2M | $1.1M | $1.4M | $1.2M | $2.2M | $1.7M | $3.0M | $2.1M | $1.7M | $1.9M | $1.4M | $1.6M | $4.7M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $3.1M | $4.4M | $3.1M | $5.8M | $8.1M | $2.7M | $5.1M | $5.1M | $6.8M | $13.3M | $15.3M | $17.1M | $2.3M | ||||||||
| Assets Current | $3.4M | $4.7M | $3.6M | $6.6M | $9.0M | $3.4M | $6.5M | $6.6M | $8.9M | $13.9M | $17.1M | $19.3M | $3.3M | ||||||||
| Assets | $4.9M | $6.4M | $5.3M | $8.4M | $10.9M | $5.1M | $8.2M | $8.5M | $10.9M | $15.7M | $18.1M | $20.1M | $3.6M | ||||||||
| Accounts Payable Current | $161.2K | $108.8K | $519.5K | $316.7K | $490.1K | $271.8K | $755.9K | $271.5K | $388.0K | $443.0K | $196.1K | $716.8K | $242.9K | ||||||||
| Common Stock Value | $164.00 | $149.00 | $55.00 | $1.8K | $258.00 | $269.00 | $16.00 | $124.00 | $102.00 | $2.0K | $2.0K | $2.0K | $2.0K | $1.1K | |||||||
| Other Assets Noncurrent | $8.7K | $22.2K | $34.4K | $23.6K | $24.4K | $25.2K | $29.9K | $31.7K | $33.4K | $33.5K | $35.1K | $20.2K | |||||||||
| Liabilities Current | $1.1M | $1.0M | $1.3M | $1.0M | $2.1M | $1.5M | $2.8M | $1.8M | $1.4M | $1.5M | $979.6K | $1.3M | |||||||||
| Operating Lease Right Of Use Asset | $134.7K | $155.7K | $176.3K | $227.5K | $263.4K | $298.7K | $367.2K | $400.6K | $433.4K | $497.6K | $573.0K | $396.7K | |||||||||
| Operating Lease Liability Noncurrent | $43.0K | $65.4K | $87.4K | $130.2K | $150.8K | $170.7K | $220.1K | $255.3K | $289.9K | $356.5K | $430.1K | $282.3K | |||||||||
| Other Liabilities Noncurrent | $5.6K | $6.6K | $7.6K | $9.5K | $10.5K | $11.4K | $13.2K | $14.1K | $15.0K | $15.4K | |||||||||||
| Operating Lease Liability Current | $100.0K | $100.0K | $100.0K | $111.5K | $128.6K | $145.8K | $168.7K | $168.7K | $168.7K | ||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $33.5K | $34.6K | $40.3K | $28.2K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.2M | $452.7K | -$3.3M | -$1.9M | |||||||||||||||||
| Accrued Liabilities Current | $1.1M | $1.4M | $863.4K | $1.1M | $783.5K | $592.6K | $371.3K | ||||||||||||||
| Additional Paid In Capital Common Stock | $43.8M | $43.8M | $40.4M | $40.4M | $40.4M | $32.6M | $29.9M | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $13.3M | $15.3M | $17.1M | $2.3M | $2.4M | $249.0K | |||||||||||||||
| Accretion Of Series Redeemable Convertible Preferred Stock Dividend | -$51.1K | -$76.7K | -$66.5K | -$66.5K | -$66.5K | ||||||||||||||||
| Repayments Of Notes Payable | $268.0K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.9M | -$663.4K | |||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | $887.7K | $832.2K | $697.2K | $552.0K | $621.1K | $1.3M | $1.1M | $1.9M | $835.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share-Based Compensation * | $6.00 | $20.1K | $189.2K | $433.0K | $68.5K | $3.7K |
| Net Cash Provided By Used In Operating Activities | -$6.1M | -$7.8M | -$8.3M | -$7.7M | -$4.4M | -$508.7K |
| Payments To Acquire Property Plant And Equipment | $173.7K | $306.8K | $704.2K | $1.2M | $23.9K | |
| Net Cash Provided By Used In Financing Activities | $7.1M | $10.2M | $1.1M | $8.1K | $22.5M | $1.3M |
| Increase Decrease In Other Noncurrent Assets | -$27.4K | $6.6K | -$6.5K | $14.2K | $21.0K | |
| Net Cash Provided By Used In Investing Activities | -$173.7K | -$306.8K | -$704.2K | -$1.2M | -$23.9K | |
| Increase Decrease In Accounts Payable | $69.1K | -$346.4K | -$235.8K | $298.9K | -$79.2K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$333.9K | -$150.3K | -$926.2K | $40.8K | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $150.9K | -$695.7K | -$30.3K | $336.6K | ||
| Payments Of Financing Costs | $4.0K | $3.8K | $4.8K | $801.00 | ||
| Stock Issued During Period Value Share Based Compensation | $433.0K | $68.5K | ||||
| Payments Of Stock Issuance Costs | $1.3M | $1.8M | $413.5K | |||
| Proceeds From Issuance Of Common Stock | $8.3M | $12.1M | $1.6M | |||
| Increase Decrease In Due From Related Parties | $2.0K | $123.1K | -$39.1K | |||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $24.4K | $433.0K | ||||
| Increase Decrease In Prepaid Expenses Other | $40.8K | $1.6M | -$19.1K | |||
| Increase Decrease In Inventories | -$84.8K | -$38.7K | ||||
| Increase Decrease In Accrued Liabilities | $336.6K | $204.8K | $152.9K | |||
| Increase Decrease In Accounts Payable Trade | -$79.2K | $345.8K | ||||
| Increase Decrease In Deferred Charges | -$265.1K | |||||
| Proceeds From Repayments Of Notes Payable | -$9.0K | $116.0K | ||||
| Proceeds From Notes Payable | $2.0M | $154.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $1.3K | $11.9K | $219.6K | $126.1K | $46.5K | $155.00 | $164.00 | $6.3K | $679.00 | -$2.5K | ||||||
| Net Cash Provided By Used In Operating Activities | -$1.2M | -$2.3M | -$2.9M | -$1.9M | -$372.6K | |||||||||||
| Payments To Acquire Property Plant And Equipment | $35.4K | $340.7K | $46.3K | |||||||||||||
| Net Cash Provided By Used In Financing Activities | -$985.00 | $2.8M | -$58.8K | -$290.8K | ||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$822.00 | -$3.4K | -$1.8K | -$788.00 | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$35.4K | -$340.7K | -$46.3K | |||||||||||||
| Increase Decrease In Accounts Payable | $374.4K | -$219.6K | -$314.8K | $421.1K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$140.9K | $41.3K | $446.5K | -$310.0K | ||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $110.3K | -$45.3K | -$14.2K | $105.2K | ||||||||||||
| Payments Of Financing Costs | $985.00 | $914.00 | $1.2K | |||||||||||||
| Stock Issued During Period Value Share Based Compensation | $27.7K | $54.7K | $113.2K | $106.1K | $126.1K | $46.5K | $155.00 | $164.00 | ||||||||
| Payments Of Stock Issuance Costs | $711.0K | $413.5K | ||||||||||||||
| Proceeds From Issuance Of Common Stock | $3.5M | |||||||||||||||
| Increase Decrease In Due From Related Parties | $2.0K | $4.0K | ||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $4.8K | $6.0K | $11.9K | -$42.5K | $27.7K | $54.7K | ||||||||||
| Increase Decrease In Prepaid Expenses Other | -$310.0K | -$787.00 | ||||||||||||||
| Increase Decrease In Inventories | $893.2K | |||||||||||||||
| Increase Decrease In Accrued Liabilities | $105.2K | $8.0K | ||||||||||||||
| Increase Decrease In Accounts Payable Trade | $421.1K | -$173.9K | ||||||||||||||
| Increase Decrease In Deferred Charges | -$265.1K | |||||||||||||||
| Proceeds From Repayments Of Notes Payable | -$9.7K | |||||||||||||||
| Proceeds From Notes Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$15.25 | -$456.75 | -$3.6K | -$9.22 | -$0.41 | -$0.37 |
| Weighted Average Number Of Shares Outstanding Basic | 449.0K | 45.8K | 2.7K | 1.0M | 8.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 449.0K | 45.8K | 2.7K | 1.0M | 8.5M | |
| Earnings Per Share Basic | $-15.25 | $-456.75 | $-3,631.48 | $-9.22 | $-0.41 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 7.5M | 100.0M | 100.0M |
| Common Stock Shares Issued | 604.5K | 138.5K | 3.1K | 1.0M | 20.1M | 3.1M |
| Common Stock Shares Outstanding | 604.5K | 138.5K | 3.1K | 1.0M | 20.1M | 3.1M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.01 | -$1.41 | -$3.37 | -$76.94 | -$256.16 | -$394.76 | -$16.67 | -$22.00 | -$2.49 | -$2.94 | -$2.00 | -$0.10 | -$0.11 | -$0.15 | -$0.04 |
| Weighted Average Number Of Shares Outstanding Basic | 1.6M | 1.4M | 554.0K | 191.1K | 9.7K | 5.9K | 137.9K | 127.9K | 1.0M | 1.0M | 1.0M | 20.1M | 10.5M | 4.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.6M | 1.4M | 554.0K | 191.1K | 9.7K | 5.9K | 137.9K | 127.9K | 1.0M | 1.0M | 1.0M | 20.1M | 10.5M | 4.2M | |
| Earnings Per Share Basic | $-1.01 | $-1.41 | $-3.37 | $-76.94 | $-256.16 | $-394.76 | $-16.67 | $-22.00 | $-2.49 | $-2.94 | $-2.00 | $-0.10 | $-0.11 | $-0.15 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 7.5M | 7.5M | 7.5M | 7.5M | 100.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | |
| Common Stock Shares Issued | 1.6M | 1.5M | 554.0K | 17.8M | 2.6M | 2.7M | 1.2M | 1.0M | 20.5M | 20.2M | 20.2M | 20.2M | 10.5M | ||
| Common Stock Shares Outstanding | 1.6M | 1.5M | 554.0K | 17.8M | 2.6M | 2.7M | 1.2M | 1.0M | 20.5M | 20.2M | 20.2M | 20.2M | 10.5M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other Income | $258.1K | $34.3K | $5.5K | |||
| Depreciation | $74.2K | $75.6K | $648.7K | $156.6K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.00 | $20.1K | $24.4K | |||
| Investment Income Interest | $97.6K | $145.8K | $164.9K | |||
| Additional Paid In Capital | $28.1M | |||||
| Depreciation And Amortization | $156.6K | $145.7K | $157.0K | |||
| Stock Issued During Period Value New Issues | $7.4M | $1.2M | $18.9M | |||
| Stock Issued During Period Value Other | $558.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Income | $70.3K | $46.4K | $43.2K | $90.7K | $139.7K | $60.4K | $48.3K | $54.9K | $2.0K | $10.0K | $848.00 | $4.00 | |||||
| Depreciation | $18.4K | $19.7K | $120.0K | $40.0K | |||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $183.00 | -$1.6K | $1.3K | $4.8K | $6.0K | $11.9K | -$42.5K | $27.7K | $54.7K | $113.2K | $106.1K | $126.1K | |||||
| Investment Income Interest | $19.0K | $29.3K | $17.8K | $61.7K | $15.4K | $30.1K | |||||||||||
| Additional Paid In Capital | $28.7M | $28.7M | $28.5M | $28.4M | $28.3M | $28.2M | $5.2M | ||||||||||
| Depreciation And Amortization | $40.0K | $40.8K | |||||||||||||||
| Stock Issued During Period Value New Issues | $7.4M | $2.8M | $1.2M | ||||||||||||||
| Stock Issued During Period Value Other | $526.00 | $307.6K | $132.4K |
Most recent annual filing with the SEC: March 6, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.